Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

During the Trading Day
0.574 +0.049 / +9.33%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.59 +0.016 / +2.79%
 
Volume: 12.2K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$83.5M

Company Description

Mast Therapeutics, Inc. is a biopharmaceutical company that is engaged in developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its lead product MST-188 has cytoprotective and hemorheologic properties and inhibits inflammatory processes and thrombosis. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Contact Information

Mast Therapeutics, Inc.
12390 El Camino Real
San Diego California 92130
P:(858) 552-0866
Investor Relations:
18585520866303

Employees

Shareholders

Other institutional17.77%
Mutual fund holders10.33%
Individual stakeholders0.27%

Top Executives

Brian M. CulleyChief Executive Officer & Director
Brandi L. RobertsChief Financial Officer, CAO & Senior VP
Edwin L. ParsleyChief Medical Officer & Senior Vice President
Robert Martin EmanueleSenior Vice President-Development
Gregory D. GorgasSenior Vice President-Commercial

To view my watchlist

Not a member yet?

Sign up now for a free account